Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome
- PMID: 1907691
- DOI: 10.2169/internalmedicine1962.30.118
Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome
Abstract
The kappa/lambda (kappa/lambda) ratios of IgG, IgA and IgM in the cerebrospinal fluid (CSF) and in the sera of 10 patients with Guillain-Barré syndrome were analyzed. The kappa/lambda ratios of IgG, IgA and IgM in the CSF and in the serum were not significantly different between the acute and the late stages of Guillain-Barré syndrome nor between Guillain-Barré syndrome and the normal controls. In the CSF, however, the concentration of albumin, IgG, IgA and IgM in the acute phases of Guillain-Barré syndrome were significantly higher than in the normal controls. These results suggest that in Guillain-Barré syndrome, the increase of immunoglobulins may not be due to intrathecal synthesis and therefore there are no significant changes in the kappa/lambda ratios in the CSF.
Similar articles
-
Oligoclonal bands staining for IgG, IgA, IgM, and kappa and lambda light chains in cerebrospinal fluid of patients with multiple sclerosis.Jpn J Psychiatry Neurol. 1988 Dec;42(4):805-9. doi: 10.1111/j.1440-1819.1988.tb01169.x. Jpn J Psychiatry Neurol. 1988. PMID: 3150478
-
Kappa/lambda ratios in IgG, IgA and IgM of cerebrospinal fluid and of sera in patients with multiple sclerosis.Autoimmunity. 1989;5(1-2):133-7. doi: 10.3109/08916938909029151. Autoimmunity. 1989. PMID: 2519013
-
[Cerebrospinal fluid IgG, IgA and IgM in healthy controls and in patients with Guillain-Barré syndrome (author's transl)].Rinsho Shinkeigaku. 1981 Jul;21(7):619-27. Rinsho Shinkeigaku. 1981. PMID: 7307403 Japanese. No abstract available.
-
[Immunoglobulins of the normal cerebrospinal fluid].Arq Neuropsiquiatr. 1979 Sep;37(3):230-49. doi: 10.1590/s0004-282x1979000300002. Arq Neuropsiquiatr. 1979. PMID: 394720 Review. Portuguese.
-
A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting.Clin Neurol Neurosurg. 2009 May;111(4):313-8. doi: 10.1016/j.clineuro.2008.12.004. Epub 2009 Jan 30. Clin Neurol Neurosurg. 2009. PMID: 19185983 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous